Park Ha Biological Technology is trading up 6.87% now at $3.39, continuing highly volatile post-reverse-split trading.

  • No clear company-specific catalyst explaining the August 14, 2026 move was found.
  • A securities-class-action deadline reminder was published around August 13–14, but it does not explicitly link the announcement to the price increase.
  • Trading activity appears relatively light at 79.95K shares versus a 1.88M average daily volume.